Previous reports had found that the chemokine receptor CCR1 was present in neurons and dystrophic processes in a small sample of AD cases [27], suggesting its overexpression as an early marker for this pathology and also opening new horizons about the role of this receptor in other neurodegenerative diseases including PD. The gene discussed is CCR1; the disease is Parkinson disease.